SCHEMBL14798705

SCHEMBL14798705

CCOC(=O)Oc1ccc(OC)c(NS(C)(=O)=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.50
KMT2A Q03164 5/20 0.49
LMNA P02545 5/20 0.49
TSHR P16473 3/20 0.49
HTT P42858 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MAPT P10636 5/20 0.47
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
PTPN1 P18031 2/20 0.47
PTPN6 P29350 1/20 0.47
MEN1 O00255 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPK1 P28482 3/20 0.46
PTK2B Q14289 1/20 0.44
POLB P06746 1/20 0.44
BRD4 O60885 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3290960 0.82 KMT2A (0.58) KMT2ALMNATSHRHTTNPSR1
SCHEMBL14799282 0.79 HPGD (0.59) THRBKMT2ALMNATSHRMAPT
SCHEMBL11014513 0.76 SMN1; SMN2 (0.48) KMT2ALMNAMAPTALDH1A1KDM4E
SCHEMBL14799077 0.76 PTGER4 (0.46) KMT2ALMNAHTTNPSR1ALDH1A1
SCHEMBL11003852 0.75 ALDH1A1 (0.53) THRBKMT2ALMNAHTTMAPT
SCHEMBL9888834 0.73 TP53 (0.61) THRBKMT2ATSHRALDH1A1GAA
SCHEMBL21991746 0.72 KMT2A (0.46) KMT2ALMNAMAPTKDM4EMEN1
SCHEMBL14452374 0.72 BRD4 (0.50) KMT2ALMNATSHRHTTNPSR1
SCHEMBL11084448 0.72 CA2 (0.42) KMT2ALMNAMAPTALDH1A1MEN1
SCHEMBL11082924 0.71 TSHR (0.46) KMT2ALMNATSHRKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9265768-B2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-02-23 US disclosed
EP-2760838-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2014-08-06 EP disclosed
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-05-22 US disclosed
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-05-22 US disclosed
WO-2013045280-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-04 WO disclosed
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-03-28 US disclosed
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A THRB 3361/4885KMT2A 2272/4885LMNA 1562/4885
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A THRB 3361/4885KMT2A 2272/4885LMNA 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.